BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.nebraska.edu

Clinical Trials

Imaging Modalities in Detection of Coronary Artery Disease in End-stage Renal Disease Patients

Completed

Conditions: Myocardial Infarction
Stroke
Coronary Artery Disease
Death

First Posted Date: 2008-08-01

Last Posted Date: 2023-09-15

Lead Sponsor: University of Nebraska

Target Recruit Count: 189

Registration Number: NCT00726921

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Assess Vitamin D Levels in Those With & Without Thyroid Cancer

Completed

Conditions: Thyroid Cancer

First Posted Date: 2008-07-21

Last Posted Date: 2023-10-16

Lead Sponsor: University of Nebraska

Target Recruit Count: 111

Registration Number: NCT00719615

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Relationship Between Physical Activity and Stem Cells in Older Adults

Completed

Conditions: Aging

First Posted Date: 2008-06-04

Last Posted Date: 2023-09-28

Lead Sponsor: University of Nebraska

Target Recruit Count: 39

Registration Number: NCT00690183

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Specialized Substance Abuse Supervision (SSAS) Versus Non-SSAS Recidivism Rates Among Nebraska Felony Drug Offenders

Completed

Conditions: Alcohol-related Disorders
Substance-related Disorders

First Posted Date: 2008-06-04

Last Posted Date: 2023-09-25

Lead Sponsor: University of Nebraska

Target Recruit Count: 344

Registration Number: NCT00690352

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer

Phase 2

Terminated

Conditions: HER2-negative Breast Cancer
Stage IIIC Breast Cancer
Stage II Breast Cancer
Stage IIIB Breast Cancer
Stage IIIA Breast Cancer

Interventions: Drug: doxorubicin hydrochloride
Drug: cyclophosphamide
Biological: bevacizumab
Drug: paclitaxel
Drug: gemcitabine hydrochloride
Other: laboratory biomarker analysis
Biological: pegfilgrastim

First Posted Date: 2008-05-16

Last Posted Date: 2023-12-11

Lead Sponsor: University of Nebraska

Target Recruit Count: 15

Registration Number: NCT00679029

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients

Not Applicable

Withdrawn

Conditions: Infection
Wounds

Interventions: Biological: autologous platelet gel

First Posted Date: 2008-05-06

Last Posted Date: 2023-08-15

Lead Sponsor: University of Nebraska

Registration Number: NCT00672672

Followup of Glenoid Fix Utilizing Auto Bone Graft in Shoulder Replacement

Completed

Conditions: Arthritis

Interventions: Procedure: X-rays and CT scan

First Posted Date: 2008-05-02

Last Posted Date: 2023-09-26

Lead Sponsor: University of Nebraska

Target Recruit Count: 29

Registration Number: NCT00670852

Locations: 🇺🇸
University of Nebraska Medical Center, Dept Orthopaedic Surgery, Omaha, Nebraska, United States

Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer

Completed

Conditions: Breast Cancer
Precancerous Condition

First Posted Date: 2008-04-25

Last Posted Date: 2023-10-10

Lead Sponsor: University of Nebraska

Target Recruit Count: 4945

Registration Number: NCT00666731

Locations: 🇺🇸
Centura - Parker Adventist Hospital, Parker, Colorado, United States
🇺🇸
Trinity Medical Center, Moline, Illinois, United States
🇺🇸
Community Hospital of Anderson and Madison County, Inc, Anderson, Indiana, United States

and more 61 locations

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Phase 2

Terminated

Conditions: Breast Cancer

Interventions: Biological: filgrastim
Drug: capecitabine
Drug: celecoxib
Drug: cyclophosphamide
Drug: docetaxel
Drug: doxorubicin hydrochloride
Genetic: gene expression analysis
Genetic: polymorphism analysis
Genetic: protein expression analysis
Genetic: reverse transcriptase-polymerase chain reaction
Other: imaging biomarker analysis
Other: immunohistochemistry staining method
Other: laboratory biomarker analysis
Other: pharmacogenomic studies
Procedure: dynamic contrast-enhanced magnetic resonance imaging
Procedure: needle biopsy
Procedure: neoadjuvant therapy
Procedure: radiomammography
Procedure: ultrasound imaging

First Posted Date: 2008-04-23

Last Posted Date: 2023-09-13

Lead Sponsor: University of Nebraska

Target Recruit Count: 3

Registration Number: NCT00665457

Locations: 🇺🇸
Unversity of Nebraska Medical Center, Omaha, Nebraska, United States

Pancreatic Cancer Collaborative Registry

Completed

Conditions: Pancreatic Cancer

First Posted Date: 2008-04-21

Last Posted Date: 2023-09-06

Lead Sponsor: University of Nebraska

Target Recruit Count: 379

Registration Number: NCT00661882

Locations: 🇺🇸
Eppley Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States

Home Terms & Conditions Privacy Policy